181 related articles for article (PubMed ID: 25317073)
21. Arsenic Trioxide Induces Apoptosis and Incapacitates Proliferation and Invasive Properties of U87MG Glioblastoma Cells through a Possible NF-κB-Mediated Mechanism.
Ghaffari SH; Yousefi M; Dizaji MZ; Momeny M; Bashash D; Zekri A; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2016; 17(3):1553-64. PubMed ID: 27039805
[TBL] [Abstract][Full Text] [Related]
22. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W
J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314
[TBL] [Abstract][Full Text] [Related]
23. Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Ye CS; Zhou DN; Yang QQ; Deng YF
Int J Clin Exp Pathol; 2014; 7(3):914-22. PubMed ID: 24696710
[TBL] [Abstract][Full Text] [Related]
24. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
Chiu HW; Ho YS; Wang YJ
J Mol Med (Berl); 2011 Sep; 89(9):927-41. PubMed ID: 21594580
[TBL] [Abstract][Full Text] [Related]
26. Upregulated TTYH2 expression is critical for the invasion and migration of U2OS human osteosarcoma cell lines.
Moon DK; Bae YJ; Jeong GR; Cho CH; Hwang SC
Biochem Biophys Res Commun; 2019 Aug; 516(2):521-525. PubMed ID: 31230749
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Li X; Ding X; Adrian TE
Cancer Invest; 2004; 22(3):389-400. PubMed ID: 15493360
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide inhibits osteosarcoma cell invasiveness via MAPK signaling pathway.
Tingting R; Wei G; Changliang P; Xinchang L; Yi Y
Cancer Biol Ther; 2010 Aug; 10(3):251-7. PubMed ID: 20592496
[TBL] [Abstract][Full Text] [Related]
29. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
Lin TH; Kuo HC; Chou FP; Lu FJ
BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study on the apoptotic effect of arsenic trioxide on human osteosarcoma MG-63 cells].
Xiao T; Li KH; Fang JZ
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):111-3. PubMed ID: 12575332
[TBL] [Abstract][Full Text] [Related]
31. ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway.
Yue B; Ren QX; Su T; Wang LN; Zhang L
Eur Rev Med Pharmacol Sci; 2014; 18(18):2640-7. PubMed ID: 25317798
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.
Huang F; Zhou P; Wang Z; Zhang XL; Liao FX; Hu Y; Chang J
Arch Biochem Biophys; 2020 Jun; 686():108351. PubMed ID: 32240636
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of SATB1 increases the invasiveness of Jurkat cell via activation of the WNT/β-catenin signaling pathway in vitro.
Luo XD; Yang SJ; Wang JN; Tan L; Liu D; Wang YY; Zheng RH; Wu XH; Xu LH; Tan H
Tumour Biol; 2016 Jun; 37(6):7413-9. PubMed ID: 26678884
[TBL] [Abstract][Full Text] [Related]
34. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
[TBL] [Abstract][Full Text] [Related]
36. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.
Zheng Y; Zhou M; Ye A; Li Q; Bai Y; Zhang Q
World J Surg Oncol; 2010 Apr; 8():31. PubMed ID: 20403207
[TBL] [Abstract][Full Text] [Related]
37. [SATB1 promotes the malignant of human non-Hodgkin lymphoma by activating the ribonucleotide reductase
small subunit M2].
Yan D; Wang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1155-1162. PubMed ID: 27932760
[TBL] [Abstract][Full Text] [Related]
38. Cathepsin L silencing increases As
Primon M; Huszthy PC; Motaln H; Talasila KM; Miletic H; Atai NA; Bjerkvig R; Lah Turnšek T
Exp Cell Res; 2017 Jul; 356(1):64-73. PubMed ID: 28412241
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.
Cao Y; Yu SL; Wang Y; Guo GY; Ding Q; An RH
Tumour Biol; 2011 Feb; 32(1):179-88. PubMed ID: 20857258
[TBL] [Abstract][Full Text] [Related]
40. Vitamin C enhances the sensitivity of osteosarcoma to arsenic trioxide via inhibiting aerobic glycolysis.
Liu Y; Yue J; Ren Z; He M; Wang A; Xie J; Li T; Liu G; He X; Ge S; Yuan Y; Yang L
Toxicol Appl Pharmacol; 2024 Jan; 482():116798. PubMed ID: 38160894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
